DEVELOPINGScientists repurpose discarded PET plastics into Parkinson's treatment drug via bacterial conversion.
Researchers from Scotland have discovered that used plastic bottles can be converted directly into L-DOPA medication for treating over 165,000 UK patients with Parkinson’s disease using a novel method involving bacteria to break down waste materials and extract the active compound required by human cells; this breakthrough demonstrates how discarded plastics could serve as valuable resources rather than environmental hazards.
Key Points
-
1Researchers from Scotland have discovered how used plastic bottles can be transformed into L-DOPA for Parkinson's disease treatment.
-
2The method utilizes specific types of genetically modified bacteria that break down the polyethylene in PET plastics to produce levulinic acid, a precursor drug ingredient.
-
3"This is not just about recycling waste; it shows we have been reimagining materials as valuable resources" - according to lead researcher Dr. James Keating.
-
4The study was published on Nature and highlights the potential for converting industrial plastic byproducts into life-saving medication.
Developments
Scientists at the University of Edinburgh engineered *E coli* bacteria to convert plastic bottles (PET) directly into L-DOPA, a gold-standard treatment for Parkinson's disease affecting 166,000 people in the UK. This biological process offers a sustainable alternative that avoids traditional fossil fuel-based pharmaceutical manufacturing by turning waste material into life-saving medication through natural processes documented in *Nature Sustainability*.